One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25 years. Among older people with diabetes, 30-45% are affected by frailty (Frailty) The risk of frailty increases with increasing HbA1c. The incidence of atherosclerotic cardiovascular disease (ASCVD) doubles with age, with a prevalence of 38.5% for coronary heart disease (CHD), 13% for stroke and 12% for peripheral arterial disease (PAD) in people aged ≥70 years. In addition to their glucose-controlling effect, new antidiabetic drugs have organ-protective benefits and have brought about a paradigm shift in diabetology.
Autoren
- Dr. med. Young Hee Lee-Barkey
- PD Dr. rer. nat. Bernd Stratmann
- Prof. Dr. med. Susanne Reger-Tan
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Diabetes mellitus
Treatment of comorbidities in older people
- Liver steatosis with metabolic dysfunction
New nomenclature for non-alcoholic fatty liver disease
- Type 2 diabetes: PAD and diabetic foot syndrome
Prevention is better than cure – don’t miss the risk foot
- Prostate cancer
High-resolution ultrasound could diagnose prostate cancer faster
- Chronic lung diseases
Sarcopenia and malnutrition in the context of pneumological rehabilitation
- Psychooncology
Communication as the key to therapy adherence
- Blastic plasmacytoid dendritic cell neoplasia
Rare malignancy from a dermatological perspective
- From symptom to diagnosis